PANK1 and cancer: Similarly, cancers with homozygous (bi-allelic) deletion of the tumor suppressor PTEN, which are typically highly aggressive, have a poor prognosis, and are refractory to treatment [22,23,24], can show co-deletion of the neighboring gene PANK1, making the redundant PANK proteins potentially attractive therapeutic targets in these cancers [25,26].